The Russian Immune Diversity Atlas project aims to profile immune cells from people of different ancestries at a multiomics level. The goal is to reconstruct a reference atlas of the healthy immune system and investigate its perturbations in Type II Diabetes (T2D). The project seeks to identify novel mechanisms and genetic/epigenetic markers for early T2D diagnostics, prognosis, and therapy as part of the international Human Cell Atlas. Why it matters: Addressing genetic diversity in biomedical research, particularly in the context of the Human Cell Atlas, is crucial for personalized medicine and ensuring that treatments are effective across diverse populations in the Middle East and globally.
KAUST researchers have discovered the first molecular events that trigger wheat's immunity to stem rust, a devastating fungal disease. The study, published in Science, identifies that tandem kinases are bound together and inactive until a pathogen binds, initiating an immune response that kills the infected cell. This prevents the pathogen from spreading and causing widespread crop damage. Why it matters: Understanding these molecular mechanisms could lead to engineering wheat with stronger and more durable resistance to stem rust and other diseases, safeguarding a crucial food source in the face of climate change and emerging pathogens.
Sahika Inal, an assistant professor of bioscience at KAUST, focuses on organic electronic materials for clinical health monitoring. Her research involves finding functional polymers and designing electronic platforms that connect biological systems with electronics. Inal notes that KAUST's facilities and collaborative environment in BESE have been crucial for her research and team growth since 2016. Why it matters: This highlights KAUST's role in fostering interdisciplinary research and attracting talented scientists in the emerging field of bioelectronics.
Juan Carlos Izpisua Belmonte from the Salk Institute discussed aging and regenerative medicine at the KAUST 2019 Winter Enrichment Program. His team is combining gene editing and stem cell technologies to grow rat organs in mice and human cells in pig and cattle embryos. The Salk team is collaborating with KAUST to rejuvenate organs using noncoding RNAs and small metabolites. Why it matters: This research collaboration between KAUST and the Salk Institute explores innovative approaches to address age-related diseases and organ regeneration, with potential long-term impacts on healthcare in the region.
KAUST researchers have discovered that a coral's resilience to rising temperatures is determined by the microorganisms living inside them. The study identifies specific combinations of microeukaryotes and bacteria that enhance heat resistance in corals. This finding provides valuable clues for developing coral probiotics to protect and restore coastal reefs. Why it matters: This breakthrough could lead to effective interventions to combat coral bleaching and preserve vital marine ecosystems in the Red Sea and beyond.
KAUST researchers have identified a protein complex of HuR and YB1 that stabilizes messenger RNA during muscle-fiber formation. The complex protects RNA as it carries muscle-forming code through the cell. Further research aims to elucidate the individual roles of each protein in the stabilization process. Why it matters: Understanding this RNA-stabilizing complex could lead to new therapies for muscle recovery and the prevention of muscle-related pathologies.
Sahika Inal is an assistant professor of bioscience at KAUST's Biological and Environmental Science and Engineering Division. She is a faculty member at King Abdullah University of Science and Technology. Why it matters: This highlights KAUST's ongoing investment in attracting research talent in bioscience.
KAUST and King Faisal Specialist Hospital and Research Centre (KFSH&RC) are collaborating to develop bioelectronic sensors for rapid pathogen detection. These sensors aim to provide cheap and accurate results, potentially replacing conventional lab tests. A COVID-19 saliva test developed by KAUST researchers showed comparable sensitivity to PCR tests with a 15-minute turnaround. Why it matters: This partnership accelerates the development of novel diagnostic tools, which could improve healthcare accessibility in remote areas and low-income countries within the region.